<VariationArchive RecordType="classified" VariationID="8286" VariationName="NM_033337.3(CAV3):c.290_292del (p.Phe97del)" VariationType="Deletion" Accession="VCV000008286" Version="5" NumberOfSubmissions="4" NumberOfSubmitters="3" DateLastUpdated="2023-08-06" DateCreated="2013-04-04" MostRecentSubmission="2018-12-15">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="23325" VariationID="8286">
      <GeneList>
        <Gene Symbol="CAV3" FullName="caveolin 3" GeneID="859" HGNC_ID="HGNC:1529" Source="submitted" RelationshipType="within multiple genes by overlap">
          <Location>
            <CytogeneticLocation>3p25.3</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="3" Accession="NC_000003.12" start="8733802" stop="8746758" display_start="8733802" display_stop="8746758" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="3" Accession="NC_000003.11" start="8775485" stop="8788450" display_start="8775485" display_stop="8788450" Strand="+" />
          </Location>
          <OMIM>601253</OMIM>
        </Gene>
        <Gene Symbol="OXTR" FullName="oxytocin receptor" GeneID="5021" HGNC_ID="HGNC:8529" Source="calculated" RelationshipType="within multiple genes by overlap">
          <Location>
            <CytogeneticLocation>3p25.3</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="3" Accession="NC_000003.12" start="8741269" stop="8769613" display_start="8741269" display_stop="8769613" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="3" Accession="NC_000003.11" start="8792093" stop="8811299" display_start="8792093" display_stop="8811299" Strand="-" />
          </Location>
          <OMIM>167055</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_033337.3(CAV3):c.290_292del (p.Phe97del)</Name>
      <CanonicalSPDI>NC_000003.12:8745698:CTTCT:CT</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>3p25.3</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="3" Accession="NC_000003.12" start="8745699" stop="8745701" display_start="8745699" display_stop="8745701" variantLength="3" positionVCF="8745698" referenceAlleleVCF="CCTT" alternateAlleleVCF="C" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="3" Accession="NC_000003.11" start="8787385" stop="8787387" display_start="8787385" display_stop="8787387" variantLength="3" positionVCF="8787384" referenceAlleleVCF="CCTT" alternateAlleleVCF="C" />
      </Location>
      <OtherNameList>
        <Name>CAV3, 3-BP DEL, PHE98DEL</Name>
        <Name>F98del</Name>
      </OtherNameList>
      <ProteinChange>F97del</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000003.11" sequenceAccession="NC_000003" sequenceVersion="11" change="g.8787387_8787389del" Assembly="GRCh37">
            <Expression>NC_000003.11:g.8787387_8787389del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000003.12" sequenceAccession="NC_000003" sequenceVersion="12" change="g.8745701_8745703del" Assembly="GRCh38">
            <Expression>NC_000003.12:g.8745701_8745703del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_008797.2" sequenceAccession="NG_008797" sequenceVersion="2" change="g.16892_16894del">
            <Expression>NG_008797.2:g.16892_16894del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001234.5" sequenceAccession="NM_001234" sequenceVersion="5" change="c.290_292del">
            <Expression>NM_001234.5:c.290_292del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001225.1" sequenceAccession="NP_001225" sequenceVersion="1" change="p.Phe97del">
            <Expression>NP_001225.1:p.Phe97del</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001822" Type="inframe_deletion" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_033337.3" sequenceAccession="NM_033337" sequenceVersion="3" change="c.290_292del" MANESelect="true">
            <Expression>NM_033337.3:c.290_292del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_203123.1" sequenceAccession="NP_203123" sequenceVersion="1" change="p.Phe97del">
            <Expression>NP_203123.1:p.Phe97del</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001822" Type="inframe_deletion" DB="SO" />
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_329" sequenceAccession="LRG_329">
            <Expression>LRG_329:g.16892_16894del</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef ID="CA119443" DB="ClinGen" />
        <XRef ID="CAV3_00014" DB="Leiden Muscular Dystrophy (CAV3)" />
        <XRef Type="Allelic variant" ID="601253.0011" DB="OMIM" />
        <XRef Type="rs" ID="199476335" DB="dbSNP" />
      </XRefList>
      <FunctionalConsequence Value="functional variant">
        <XRef ID="SO:0001536" DB="Sequence Ontology" />
      </FunctionalConsequence>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_033337.3(CAV3):c.290_292del (p.Phe97del) AND Elevated circulating creatine kinase concentration" Accession="RCV000008781" Version="4">
        <ClassifiedConditionList TraitSetID="2270">
          <ClassifiedCondition DB="MedGen" ID="C0241005">Elevated circulating creatine kinase concentration</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="2005-01-01" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_033337.3(CAV3):c.290_292del (p.Phe97del) AND Rippling muscle disease 2" Accession="RCV000008782" Version="5">
        <ClassifiedConditionList TraitSetID="6603">
          <ClassifiedCondition DB="MedGen" ID="C1832560">Rippling muscle disease 2</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="2005-01-01" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_033337.3(CAV3):c.290_292del (p.Phe97del) AND not provided" Accession="RCV000024390" Version="6">
        <ClassifiedConditionList TraitSetID="9460">
          <ClassifiedCondition DB="MedGen" ID="CN517202">not provided</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2015-08-26" SubmissionCount="2">Uncertain significance</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2015-08-26" NumberOfSubmissions="4" NumberOfSubmitters="3" DateCreated="2013-04-04" MostRecentSubmission="2018-12-15">
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Description>Uncertain significance</Description>
        <Citation Type="general">
          <ID Source="PubMed">14663034</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">15580566</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">30055862</ID>
        </Citation>
        <Citation Type="general">
          <URL>http://www.egl-eurofins.com/emvclass/emvclass.php?approved_symbol=CAV3</URL>
        </Citation>
        <DescriptionHistory Dated="2018-05-29">
          <Description>Conflicting classifications of pathogenicity</Description>
        </DescriptionHistory>
        <DescriptionHistory Dated="2017-06-30">
          <Description>Conflicting classifications of pathogenicity, not provided</Description>
        </DescriptionHistory>
        <DescriptionHistory Dated="2016-12-05">
          <Description>Pathogenic</Description>
        </DescriptionHistory>
        <ConditionList>
          <TraitSet ID="9460" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="17556" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">none provided</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">not provided</ElementValue>
                <XRef ID="13DG0619" DB="Developmental Genetics Unit, King Faisal Specialist Hospital &amp; Research Centre" />
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">The term 'not provided' is registered in MedGen to support identification of submissions to ClinVar for which no condition was named when assessing the variant. 'not provided' differs from 'not specified', which is used when a variant is asserted to be benign, likely benign, or of uncertain significance for conditions that have not been specified.</Attribute>
              </AttributeSet>
              <XRef ID="CN517202" DB="MedGen" />
            </Trait>
          </TraitSet>
          <TraitSet ID="6603" Type="Disease" ContributesToAggregateClassification="false">
            <Trait ID="3628" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Limb-girdle muscular dystrophy, type 1C</ElementValue>
                <XRef ID="Limb-girdle+muscular+dystrophy%2C+type+1C/8748" DB="Genetic Alliance" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Rippling muscle disease 2</ElementValue>
                <XRef ID="MONDO:0019947" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">CAV3-Related Rippling Muscle Disease</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">RMD2</ElementValue>
                <XRef ID="GTR000558540" DB="Genetic Testing Registry (GTR)" />
                <XRef Type="MIM" ID="606072" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">LGMD1C</ElementValue>
                <XRef Type="MIM" ID="607801" DB="OMIM" />
                <XRef Type="MIM" ID="606072" DB="OMIM" />
              </Symbol>
              <XRef ID="265" DB="Orphanet" />
              <XRef ID="C1832560" DB="MedGen" />
              <XRef ID="MONDO:0019947" DB="MONDO" />
              <XRef Type="MIM" ID="606072" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="2270" Type="Disease" ContributesToAggregateClassification="false">
            <Trait ID="1198" Type="Finding">
              <Name>
                <ElementValue Type="Alternate">Elevated serum creatine phosphokinase</ElementValue>
                <XRef ID="HP:0003236" DB="Human Phenotype Ontology" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Elevated circulating creatine kinase concentration</ElementValue>
                <XRef ID="HP:0003236" DB="Human Phenotype Ontology" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">HYPERCKEMIA, IDIOPATHIC</ElementValue>
                <XRef Type="MIM" ID="123320" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">CAV3-Related Isolated HyperCKemia</ElementValue>
              </Name>
              <XRef ID="C0241005" DB="MedGen" />
              <XRef ID="MONDO:0007402" DB="MONDO" />
              <XRef Type="MIM" ID="123320" DB="OMIM" />
              <XRef Type="primary" ID="HP:0003236" DB="Human Phenotype Ontology" />
              <XRef Type="secondary" ID="HP:0002147" DB="Human Phenotype Ontology" />
              <XRef Type="secondary" ID="HP:0002906" DB="Human Phenotype Ontology" />
              <XRef Type="secondary" ID="HP:0003078" DB="Human Phenotype Ontology" />
              <XRef Type="secondary" ID="HP:0003525" DB="Human Phenotype Ontology" />
              <XRef Type="secondary" ID="HP:0003531" DB="Human Phenotype Ontology" />
              <XRef Type="secondary" ID="HP:0008164" DB="Human Phenotype Ontology" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="50982" SubmissionDate="2012-04-15" DateLastUpdated="2013-04-04" DateCreated="2013-04-04">
        <ClinVarSubmissionID localKey="CAV3_00014" />
        <ClinVarAccession Accession="SCV000045684" DateUpdated="2013-04-04" DateCreated="2013-04-04" Type="SCV" Version="1" SubmitterName="Leiden Muscular Dystrophy (CAV3)" OrgID="500012" OrganizationCategory="locus-specific database (LSDB)" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2012-04-15">
          <ReviewStatus>no classification provided</ReviewStatus>
          <GermlineClassification>not provided</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>curation</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <CitationList>
            <Citation>
              <ID Source="PubMed">14663034</ID>
            </Citation>
            <Citation>
              <ID Source="PubMed">17994539</ID>
            </Citation>
          </CitationList>
          <FunctionalConsequence Value="has functional consequence" />
          <AttributeSet>
            <Attribute Type="HGVS">r.(?)</Attribute>
          </AttributeSet>
          <AttributeSet>
            <Attribute Type="HGVS">p.(Phe97del)</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">not specified</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
      <ClinicalAssertion ID="28991" SubmissionDate="2018-09-27" DateLastUpdated="2018-09-30" DateCreated="2013-04-04">
        <ClinVarSubmissionID localKey="601253.0011_CREATINE PHOSPHOKINASE, ELEVATED SERUM" title="CAV3, 3-BP DEL, PHE98DEL_CREATINE PHOSPHOKINASE, ELEVATED SERUM" />
        <ClinVarAccession Accession="SCV000028991" DateUpdated="2018-09-30" DateCreated="2013-04-04" Type="SCV" Version="3" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2005-01-01">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">The numbering of this CAV3 mutation is based on the numbering system used by Fulizio et al. (2005). Early reports designated this mutation PHE97DEL.</Attribute>
              <Citation>
                <ID Source="PubMed">15580566</ID>
              </Citation>
            </ObservedData>
            <ObservedData>
              <Attribute Type="Description">Cagliani et al. (2003) reported a multigenerational Italian family with deletion of nucleotides 328-330 in the CAV3 gene, resulting in deletion of phenylalanine at codon 97. All members with the mutation had elevated serum creatine kinase (123320), but there was remarkable intrafamilial variation in other features, including rippling muscle disease (RMD2; 606072), proximal limb weakness, distal limb weakness, and what was considered to be a more severe limb-girdle muscular dystrophy (LGMD1C), which was reclassified by Straub et al. (2018) as rippling muscle disease. Muscle biopsy of 3 affected patients showed myopathic changes and a deficiency of caveolin-3 by immunostaining and Western blot analysis. A heart biopsy in 1 patient showed that caveolin-3 was present at approximately 60% of the normal level. Cagliani et al. (2003) noted that the findings provided an explanation of why heart involvement is not a feature of caveolinopathies, and suggested that the molecular network acting with caveolin-3 in skeletal muscle and heart may differ.</Attribute>
              <Citation>
                <ID Source="PubMed">14663034</ID>
              </Citation>
              <Citation>
                <ID Source="PubMed">30055862</ID>
              </Citation>
              <XRef DB="OMIM" ID="123320" Type="MIM" />
              <XRef DB="OMIM" ID="606072" Type="MIM" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="CAV3" />
          </GeneList>
          <Name>CAV3, 3-BP DEL, PHE98DEL</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">3-BP DEL, PHE98DEL</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="601253.0011" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">CREATINE PHOSPHOKINASE, ELEVATED SERUM</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
      <ClinicalAssertion ID="28992" SubmissionDate="2018-09-27" DateLastUpdated="2018-09-30" DateCreated="2013-04-04">
        <ClinVarSubmissionID localKey="601253.0011_RIPPLING MUSCLE DISEASE 2" title="CAV3, 3-BP DEL, PHE98DEL_RIPPLING MUSCLE DISEASE 2" />
        <ClinVarAccession Accession="SCV000028992" DateUpdated="2018-09-30" DateCreated="2013-04-04" Type="SCV" Version="3" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2005-01-01">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to included disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">The numbering of this CAV3 mutation is based on the numbering system used by Fulizio et al. (2005). Early reports designated this mutation PHE97DEL.</Attribute>
              <Citation>
                <ID Source="PubMed">15580566</ID>
              </Citation>
            </ObservedData>
            <ObservedData>
              <Attribute Type="Description">Cagliani et al. (2003) reported a multigenerational Italian family with deletion of nucleotides 328-330 in the CAV3 gene, resulting in deletion of phenylalanine at codon 97. All members with the mutation had elevated serum creatine kinase (123320), but there was remarkable intrafamilial variation in other features, including rippling muscle disease (RMD2; 606072), proximal limb weakness, distal limb weakness, and what was considered to be a more severe limb-girdle muscular dystrophy (LGMD1C), which was reclassified by Straub et al. (2018) as rippling muscle disease. Muscle biopsy of 3 affected patients showed myopathic changes and a deficiency of caveolin-3 by immunostaining and Western blot analysis. A heart biopsy in 1 patient showed that caveolin-3 was present at approximately 60% of the normal level. Cagliani et al. (2003) noted that the findings provided an explanation of why heart involvement is not a feature of caveolinopathies, and suggested that the molecular network acting with caveolin-3 in skeletal muscle and heart may differ.</Attribute>
              <Citation>
                <ID Source="PubMed">14663034</ID>
              </Citation>
              <Citation>
                <ID Source="PubMed">30055862</ID>
              </Citation>
              <XRef DB="OMIM" ID="123320" Type="MIM" />
              <XRef DB="OMIM" ID="606072" Type="MIM" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="CAV3" />
          </GeneList>
          <Name>CAV3, 3-BP DEL, PHE98DEL</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">3-BP DEL, PHE98DEL</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="601253.0011" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="included">RIPPLING MUSCLE DISEASE 2</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
      <ClinicalAssertion ID="647440" SubmissionDate="2018-09-19" DateLastUpdated="2018-12-15" DateCreated="2016-12-06">
        <ClinVarSubmissionID localKey="33222_000000" localKeyIsSubmitted="1" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000333917" DateUpdated="2018-12-15" DateCreated="2016-12-06" Type="SCV" Version="4" SubmitterName="Eurofins Ntd Llc (ga)" OrgID="500060" OrganizationCategory="laboratory" OrgAbbreviation="EGL" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2015-08-26">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Uncertain significance</GermlineClassification>
          <Citation>
            <ID Source="PubMed">14663034</ID>
          </Citation>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">EGL Classification Definitions 2015</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/ahdynye1/egl_classification_definitions_2015.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
              <Gender>mixed</Gender>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="VariantAlleles" integerValue="1" />
            </ObservedData>
            <ObservedData>
              <Attribute Type="SingleHeterozygote" integerValue="1" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="CAV3" />
          </GeneList>
          <VariantType>Deletion</VariantType>
          <Location>
            <SequenceLocation Assembly="GRCh37" Chr="3" alternateAllele="-" referenceAllele="TCT" start="8787387" stop="8787389" variantLength="3" />
            <GeneLocation>NM_033337.2:Ex2</GeneLocation>
          </Location>
          <XRefList>
            <XRef DB="HGMD" ID="CD034765" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">not provided</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <Citation>
          <URL>http://www.egl-eurofins.com/emvclass/emvclass.php?approved_symbol=CAV3</URL>
        </Citation>
        <SubmissionNameList>
          <SubmissionName>SUB4534263</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="50982" TraitType="Disease" MappingType="Name" MappingValue="not specified" MappingRef="Preferred">
        <MedGen CUI="CN169374" Name="not specified" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="28991" TraitType="Disease" MappingType="Name" MappingValue="CREATINE PHOSPHOKINASE, ELEVATED SERUM" MappingRef="Preferred">
        <MedGen CUI="C0241005" Name="Elevated circulating creatine kinase concentration" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="647440" TraitType="Disease" MappingType="Name" MappingValue="not provided" MappingRef="Preferred">
        <MedGen CUI="CN517202" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="28992" TraitType="Disease" MappingType="Name" MappingValue="RIPPLING MUSCLE DISEASE 2" MappingRef="Alternate">
        <MedGen CUI="C1832560" Name="Rippling muscle disease 2" />
      </TraitMapping>
    </TraitMappingList>
    <DeletedSCVList>
      <SCV>
        <Accession Version="2" DateDeleted="2018-09-27">SCV000028993</Accession>
      </SCV>
    </DeletedSCVList>
  </ClassifiedRecord>
</VariationArchive>

